Westminster Scotland Wales London Northern Ireland European Union Local
ePolitix.com

 
[ Advanced Search ]

Login | Contact | Terms | Accessibility
MS drugs to be rationed

A leaked report from the NHS drugs body NICE has revealed that the use of expensive multiple sclerosis treatments is to be "strictly limited".

Published: Tue, 7 Aug 2001 01:00:00 GMT+01

» STAKEHOLDER LINKS
ABDO - ABDO and the NHS
Age Concern - ePolitix Consultations
ARPO50 - Welcome
Association of British Insurers
Atos Origin
Babraham Institute - Welcome
Beating Bowel Cancer
British Pregnancy Advisory Service - Current Issues
BUPA - Press Releases
Business Services Association - Welcome
Carers UK - Welcome
CLIC - Welcome
Commission for Social Care Inspection - Welcome
Construction Products Association
Council of Heads of Medical Schools' - Press Releases
Counsel and Care - Welcome
Depression Alliance - ePolitix Consultations
Disabilities Trust - Issues that affect the Trust
Electrical Contractors Association - Welcome
Forum of Private Business
General Medical Council - Welcome
GMB - About us
Guide Dogs for the Blind Association
Health Professions Council - About the Health Professions Council
Help the Aged - ePolitix Consultations
Homeless Link
Institute of Directors - Policy Documents
Insulin Dependent Diabetes Trust - ePolitix Consultations
Johnson Matthey - Welcome
Joseph Rowntree Foundation - Other Social policy
Leonard Cheshire
Local Government Information Unit - Welcome
Medical Research Council - Welcome
MUTUO - Media releases
National Institute for Health and Clinical Excellence - Press Releases
National Office of Animal Health - Welcome
National Pharmaceutical Association - Welcome
NHS Confederation
NMC - ePolitix Consultations
Pfizer - About Pfizer
Royal College of Physicians
SANE - ePolitix Consultations
SCOP - SCOP policy responses
Shire Pharmaceuticals - Welcome
Stroke Association - ePolitix Consultations
Which?

» FURTHER READING
Telegraph - page 11 | Independent - page 7 | Mail - page 31

©2005 ePolitix.com

About ePolitix.com | About Stakeholders | Contact | Help | Register | Terms | Accessibility